Acceleron Pharma
XLRN
#1821
Rank
โ‚ฌ9.96 B
Marketcap
162,88ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,821.31%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.25 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ0.10 Billion. In 2020 the company made a revenue of โ‚ฌ84.3 Million an increase over the revenue in the year 2019 that were of โ‚ฌ67.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.25 M12.98%
2020โ‚ฌ84.3 M25.05%
2019โ‚ฌ67.42 M428.85%
2018โ‚ฌ12.74 M3.78%
2017โ‚ฌ12.28 M-51.45%
2016โ‚ฌ25.3 M53.47%
2015โ‚ฌ16.48 M23.68%
2014โ‚ฌ13.33 M-74.43%
2013โ‚ฌ52.14 M275.17%
2012โ‚ฌ13.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ90.51 B 87,991.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ57.97 B 56,322.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ35.44 B 34,399.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ15.39 B 14,883.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ31.48 M-69.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.2 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ94.71 M-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA